8-benzyl-6-(2,6-dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]pyrido[2,3-d]pyrimidin-7-one
C32H31Cl2N5O2 — CID 135382621
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-benzyl-6-(2,6-dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]pyrido[2,3-d]pyrimidin-7-one
8-benzyl-6-(2,6-dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]pyrido[2,3-d]pyrimidin-7-one (PubChem CID 135382621) has the molecular formula C32H31Cl2N5O2 and a molecular weight of 588.54 g/mol. Its IUPAC name is 8-benzyl-6-(2,6-dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]pyrido[2,3-d]pyrimidin-7-one.
Molecular Properties
| Compound Name | 8-benzyl-6-(2,6-dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]pyrido[2,3-d]pyrimidin-7-one |
|---|---|
| PubChem CID | 135382621 |
| Molecular Formula | C32H31Cl2N5O2 |
| Molecular Weight | 588.54 g/mol |
| Exact Mass | 587.19 |
| IUPAC Name | 8-benzyl-6-(2,6-dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]pyrido[2,3-d]pyrimidin-7-one |
| SMILES | CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(Cc4ccccc4)c3n2)cc1 |
| InChI | InChI=1S/C32H31Cl2N5O2/c1-3-38(4-2)17-18-41-25-15-13-24(14-16-25)36-32-35-20-23-19-26(29-27(33)11-8-12-28(29)34)31(40)39(30(23)37-32)21-22-9-6-5-7-10-22/h5-16,19-20H,3-4,17-18,21H2,1-2H3,(H,35,36,37) |
| InChIKey | KWZMLARYZJWIGD-UHFFFAOYSA-N |
| XLogP | 7.28 |
| TPSA | 72.28 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 588.54 |
| LogP ≤ 5 | 7.28 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135382621 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.